Kyle Rose
Stock Analyst at Canaccord Genuity
(2.64)
# 2,015
Out of 5,124 analysts
115
Total ratings
52.69%
Success rate
13.43%
Average return
Main Sectors:
Stocks Rated by Kyle Rose
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PODD Insulet | Maintains: Buy | $432 → $450 | $284.24 | +58.32% | 17 | Dec 17, 2025 | |
| SNN Smith & Nephew | Maintains: Hold | $27 | $32.81 | -17.71% | 6 | Feb 26, 2025 | |
| SYK Stryker | Maintains: Buy | $420 → $435 | $351.47 | +23.77% | 20 | Jan 29, 2025 | |
| GMED Globus Medical | Maintains: Buy | $67 → $71 | $87.31 | -18.68% | 7 | Dec 20, 2023 | |
| ENOV Enovis | Maintains: Buy | $65 → $71 | $26.64 | +166.52% | 3 | Dec 20, 2023 | |
| INMD InMode | Downgrades: Hold | $55 → $22 | $14.69 | +49.76% | 10 | Oct 13, 2023 | |
| SKIN The Beauty Health Company | Assumes: Buy | $10 | $1.39 | +619.42% | 4 | Aug 25, 2023 | |
| ATEC Alphatec Holdings | Maintains: Buy | $17 → $22 | $21.04 | +4.56% | 4 | Aug 4, 2023 | |
| DXCM DexCom | Maintains: Buy | $135 → $150 | $66.37 | +126.01% | 17 | Jul 28, 2023 | |
| RBOT Vicarious Surgical | Maintains: Buy | $360 → $270 | $2.17 | +12,342.40% | 3 | May 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $24 → $27 | $19.72 | +36.92% | 3 | May 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $1.18 | +1,171.19% | 1 | Mar 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $32.73 | -54.17% | 6 | Mar 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $125 → $122 | $161.96 | -24.67% | 1 | Mar 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $3 → $4 | $5.80 | -31.03% | 4 | Nov 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $7.44 | - | 2 | Nov 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $165 → $125 | $89.92 | +39.01% | 7 | Feb 8, 2022 |
Insulet
Dec 17, 2025
Maintains: Buy
Price Target: $432 → $450
Current: $284.24
Upside: +58.32%
Smith & Nephew
Feb 26, 2025
Maintains: Hold
Price Target: $27
Current: $32.81
Upside: -17.71%
Stryker
Jan 29, 2025
Maintains: Buy
Price Target: $420 → $435
Current: $351.47
Upside: +23.77%
Globus Medical
Dec 20, 2023
Maintains: Buy
Price Target: $67 → $71
Current: $87.31
Upside: -18.68%
Enovis
Dec 20, 2023
Maintains: Buy
Price Target: $65 → $71
Current: $26.64
Upside: +166.52%
InMode
Oct 13, 2023
Downgrades: Hold
Price Target: $55 → $22
Current: $14.69
Upside: +49.76%
The Beauty Health Company
Aug 25, 2023
Assumes: Buy
Price Target: $10
Current: $1.39
Upside: +619.42%
Alphatec Holdings
Aug 4, 2023
Maintains: Buy
Price Target: $17 → $22
Current: $21.04
Upside: +4.56%
DexCom
Jul 28, 2023
Maintains: Buy
Price Target: $135 → $150
Current: $66.37
Upside: +126.01%
Vicarious Surgical
May 31, 2023
Maintains: Buy
Price Target: $360 → $270
Current: $2.17
Upside: +12,342.40%
May 2, 2023
Maintains: Buy
Price Target: $24 → $27
Current: $19.72
Upside: +36.92%
Mar 28, 2023
Reiterates: Buy
Price Target: $15
Current: $1.18
Upside: +1,171.19%
Mar 28, 2023
Reiterates: Buy
Price Target: $15
Current: $32.73
Upside: -54.17%
Mar 1, 2023
Maintains: Market Perform
Price Target: $125 → $122
Current: $161.96
Upside: -24.67%
Nov 10, 2022
Upgrades: Buy
Price Target: $3 → $4
Current: $5.80
Upside: -31.03%
Nov 9, 2022
Downgrades: Hold
Price Target: n/a
Current: $7.44
Upside: -
Feb 8, 2022
Downgrades: Hold
Price Target: $165 → $125
Current: $89.92
Upside: +39.01%